Biblio

Author Title [ Type

] Year

Filters: Author is Wagner-Drouet, Eva-Maria [Clear All Filters]

Journal Article

Kriege O, Kreft A, Hauptrock B, Wölfinger P, Theobald M, Wagner-Drouet E-M. Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?. Ann Hematol. 2023.

Beelen DWilhelm, Iacobelli S, Koster L, Eikema D-J, van Biezen A, Stölzel F, Ciceri F, Bethge W, Dreger P, Wagner-Drouet E-M, et al. Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone Marrow Transplant. 2024.

Stelljes M, Middeke JMoritz, Bug G, Wagner-Drouet E-M, Müller LP, Schmid C, Krause SW, Bethge W, Jost E, Platzbecker U, et al. Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial. Lancet Haematol. 2024.

Beelen DWilhelm, Trenschel R, Stelljes M, Groth C, Masszi T, Reményi P, Wagner-Drouet E-M, Hauptrock B, Dreger P, Luft T, et al. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 . Lancet Haematol. 2019.

Kreft A, Alverson C, Wagner-Drouet E-M, Ries I, Sommer C, Nat MSchindelde. Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study. Pathol Res Pract. 2022;231:153799.